awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35622440-12DB7382-F47F-40D4-A70B-5ECA2C1273D3
Q35622440-12DB7382-F47F-40D4-A70B-5ECA2C1273D3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35622440-12DB7382-F47F-40D4-A70B-5ECA2C1273D3
Cancer treatment with kinase inhibitors: what have we learnt from imatinib?
P2860
Q35622440-12DB7382-F47F-40D4-A70B-5ECA2C1273D3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35622440-12DB7382-F47F-40D4-A70B-5ECA2C1273D3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c65ee815ae3b5191cf1ec2af06100f4cef801497
P2860
Sustained complete hematologic remission after administration of the tyrosine kinase inhibitor imatinib mesylate in a patient with refractory, secondary AML.